Global Digital Pills Market rising at CAGR of 7.90% Owing to Advancements in Health Tracking Tools

Digital Pills Market is expected to rise at the progressive growth rate of 7.90% annually during the forecast period of 2019 to 2026. The surging ratio of chronic diseases and reduced expenditure from misused medications is driving the digital pills market growth, which is expected to deliver the USD 302.70 million by 2026.

In March 2018, the PEAR Therapeutics, the pioneer director in FDA, unblocked direction for digital remedial and registered into an establishing agreement with Novartis, a pharma corporation to generate digital medication for schizophrenia and various sclerosis. Certain digital tablets are compatible with software applications formed to strategically enhance clinical outcomes for sufferers.

Digital Pills Market Scenario

According to Data Bridge Market Research the market for digital pills market is germinating owing to certain parameters, such as the more accelerated healing rates from more elevated adherence to the medication regimen and swift outcomes which boost the growth of the digital pills market.

Rising research and development expenditure, as well as technological progression by businesses in tracking devices, have led to a transmutation in digital capsules, and expanding pervasiveness of disorders such as diabetes and other cardiovascular ailments and the demand for their medication via controlled dosage is expected to raise the market growth.

On the contrary, dearth of awareness concerning digital pills inhibits the increase during the approaching years.

For more analysis on the digital pills market request for a briefing with our analysts

Digital Pills Market Developments in 2019

  • In December, via the information from verywellhealth digital magazine, the recent product launch and update are as follows. The appearance of a “smart pill” that is installed with a sensor soon submits a unique way of tracing pill acquiescence. This latest health technology has earned a lot of scientific and media recognition and from the public domain. Technology revealed by Proteus has been suited to other fields of medication. The ingestible sensor gained FDA endorsement previously in 2012. Since then it's used to compose sensor-enabled pills for uncontrolled hypertension and type two diabetes.

Scope of the Digital Pills Market

The digital pills market is segmented on the basis of countries into U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

  • All country based analysis of the digital pills market is further analysed based on maximum granularity into further segmentation. On the basis of diseases, the market is segmented into cardiovascular diseases, infectious diseases, diabetes, cancer, and others. Based on end user, the market is segmented into hospitals, clinics, home care settings, and others.

To know more about the study

Key Pointers Covered in the Digital Pills Market Industry Trends and Forecast to 2026

  • Market Size
  • Market New Sales Volumes
  • Market Replacement Sales Volumes
  • Market Installed Base
  • Market By Brands
  • Market Procedure Volumes
  • Market Product Price Analysis
  • Market Healthcare Outcomes
  • Market Cost of Care Analysis
  • Market Regulatory Framework and Changes
  • Market Prices and Reimbursement Analysis
  • Market Shares in Different Regions
  • Recent Developments for Market Competitors
  • Market Upcoming Applications
  • Market Innovators Study

Key Market Competitors Covered in the Report

  • Proteus Digital Health
  • Ostuka Holdings Co., Ltd.
  • 2morrow Inc.
  • Ginger
  • Puretech Health
  • Livongo Health
  • Alivecor, Inc.
  • Welldoc, Inc.
  • Omada Health, Inc.
  • Novartis Ag
  • Yuza.
  • Abbott
  • Mocacare
  • Gentag, Inc.
  • Irhythm Technologies, Inc.
  • Leaf Healthcare, Inc.
  • Perficient, Inc.
  • Olympus Corporation
  • Bdd Limited
  • Capsocam Plus
  • Medtronic

Above are the key players covered in the report, to know about more and exhaustive list of digital pills companies’ contact us

Research Methodology: Global Digital Pills Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Related Reports

Browse in Healthcare Category Related Reports@